Mildronate decreases carnitine availability and up-regulates glucose uptake and related gene expression in the mouse heart
- 24 October 2008
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 83 (17-18), 613-619
- https://doi.org/10.1016/j.lfs.2008.08.008
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Heart Failure in Diabetes and Related ConditionsJournal of Cardiac Failure, 2007
- Metabolic Mechanisms in Heart FailureCirculation, 2007
- Regulation of Lipid Flux between Liver and Adipose Tissue during Transient Hepatic Steatosis in Carnitine-depleted RatsPublished by Elsevier BV ,2007
- New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscleThe Journal of Physiology, 2007
- Anti-anginal effects of partial fatty acid oxidation inhibitorsCurrent Opinion in Pharmacology, 2007
- Inhibition of free fatty acids metabolism as a therapeutic target in patients with heart failureInternational Journal of Clinical Practice, 2007
- Mildronate, an Inhibitor of Carnitine Biosynthesis, Induces an Increase in Gamma-Butyrobetaine Contents and Cardioprotection in Isolated Rat Heart InfarctionJournal of Cardiovascular Pharmacology, 2006
- Adaptation and Maladaptation of the Heart in Diabetes: Part ICirculation, 2002
- Sodium pivalate reduces cardiac carnitine content and increases glucose oxidation without affecting cardiac functional capacityLife Sciences, 1995
- Muscle-specific expression of human insulin receptor in transgenic miceDiabetes, 1993